Belbuca and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Belbuca (buprenorphine hydrochloride) and Abilify (aripiprazole). Common drug interactions include musculoskeletal disorder among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Belbuca and Abilify. It is created by eHealthMe based on reports of 10 people who take the same drugs from the FDA, and is updated regularly.

What is Belbuca?

Belbuca has active ingredients of buprenorphine hydrochloride. eHealthMe is studying from 3,022 Belbuca users. Check the latest studies of Belbuca.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

On Jul, 21, 2026

10 people who take Belbuca and Abilify together, and have interactions are studied.

What are the common drug interactions of Belbuca and Abilify, by gender? *:

female:

Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Therapeutic response unexpected
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Oligomenorrhoea (infrequent (or, in occasional usage, very light) menstruation)
Pain in extremity
Gait disturbance
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Back disorder
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Fatigue (feeling of tiredness)

male:

Fall
Tardive dyskinesia (a disorder that involves involuntary movements)

What are the common drug interactions of Belbuca and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Oligomenorrhoea (infrequent (or, in occasional usage, very light) menstruation)
Pain in extremity
Headache (pain in head)

40-49:

Fall
Insomnia (sleeplessness)
Malaise (a feeling of general discomfort or uneasiness)
Mobility decreased (ability to move is reduced)
Muscle strain (an injury to a muscle in which the muscle fibres tear)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Therapeutic response unexpected
Renal failure (kidney dysfunction)
Chronic kidney disease
Contusion (a type of hematoma of tissue in which capillaries)

50-59:

Gait disturbance
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Fatigue (feeling of tiredness)
Somnolence (a state of near-sleep, a strong desire for sleep)
Urinary tract infection

60+:

Fall
Tardive dyskinesia (a disorder that involves involuntary movements)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 40.00%
Pain: 3 people, 30.00%
Stress And Anxiety: 3 people, 30.00%
High Blood Cholesterol: 3 people, 30.00%
Migraine (headache): 3 people, 30.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 30.00%
Inflammation: 2 people, 20.00%
Infection: 2 people, 20.00%
Immune System Disorder: 2 people, 20.00%
Hypokalemia (low potassium): 2 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Belbuca and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously